Adebola Busola Ojo, Oluwafemi Adeleke Ojo, Mary Abiola Okesola, Basiru Olaitan Ajiboye and Babatunji Emmanuel Oyinloye
flavonoid compounds from Scutellaria indica Archives Pharmacal Res 2013; 36: 922-9. https://doi.org/10.1007/s12272-013-0125-3
34. Segal R, Hannan JL, Liu X, et al. Chronic Oral Administration of the Arginase Inhibitor 2(S)-amino-6-boronohexanoic Acid (ABH) Improves ErectileFunction in Aged Rats. J Androl 2012; 33: 1169-75. https://doi.org/10.2164/jandrol.111.015834
35. Cassidy A, Franz M, Rimm EB. Dietary flavonoid intake and incidence of erectile Dysfunction. Am J Clin Nutr 2016; 106: 534-41. https://doi.org/10.3945/ajcn.115.122010
36. Farombi EO
Boyan A. Stoykov, Nikolay H. Kolev, Rumen P. Kotsev, Fahd Al-Shargabi, Pencho P. Genov, Aleksandar Vanov, Jitian A. Atanasov, Manish Sachdeva, Pencho T. Tonchev and Maria I. Koleva
, Gallina A, Suardi N, Capitanio U, et al. Choosing the best candidates for penile rehabilitation after bilateral nerve-sparing radical prostatectomy. J Sex Med. 2012;9(2):608-17.
16. Briganti A, Gallina A, SuardiN, Capitanio U, Tutolo M, Bianchi M, et al. Predicting erectilefunction recovery after bilateral nerve sparing radical prostatectomy: a proposal of a novel preoperative risk stratification. J Sex Med. 2010;7(7):2521-31.
17. Briganti A, Capitanio U, Chun FK, Karakiewicz PI, Salonia A, Bianchi M, et al. Prediction of sexual function after radical
Boyan A. Stoykov, Nikolay H. Kolev, Rumen P.Kotsev, Fahd Al-Shargabi, Pencho P. Genov, Aleksandar Vanov, Jitian A. Atanasov, Manish Sachdeva, Pencho T. Tonchev and Maria I. Koleva
-intensity shock wave therapy: a promising novel modality for erectile dysfunction. Korean J Urol. 2014;55(5):295-9.
16. Vardi Y, Appel B, Jacob G, Massarwi O, Gruenwald I. Can low-intensity extracorporeal shockwave therapy improve erectilefunction? A 6-month follow-up pilot study in patients with organic erectile dysfunction. Eur Urol. 2010; 58(2):243-8.
17. Chung E, Cartmill R. Evaluation of clinical efficacy, safety and patient satisfaction rate after low-intensity extracorporeal shockwave therapy for the treatment of male erectile dysfunction: an Australian
F, Demirel F, Ozgunay T, Altug U. Is dorsale penile vein ligation (DPVL) still a treatment option in veno-occlusive dysfunction? Int Urol Nephrol 2003; 35 : 529-34.
Sarramon JP, Malavaud B, Braud F, Bertrand N, Vaessen C, Rischmann P. Evaluation of male sexual function by the International Index of ErectileFunction after deep dorsal vein arterialization of the penis. J Urol 2001; 166 : 576-80.
Bertolotto M, Serafini G, Savoca G, Liguori G, Calderan L, Gasparini C, et al. Color Doppler US of the
Ryszard Plinta, Joanna Sobiecka, Agnieszka Drosdzol-Cop, Agnieszka Nowak-Brzezińska and Violetta Skrzypulec-Plinta
Alexander MS, Brackett NL, Bodner D, Elliott S, Jackson A, Sonksen J. National Institute on Disability and Rehabilitation Research. Measurement of sexual functioning after spinal cord injury: preferred instruments. J Spinal Cord Med, 2009; 32: 226-236
Cappelleri JC, Rosen RC, Smith MD, Mishra A, Osterloh IH. Diagnostic evaluation of the erectilefunction domain of the International Index of ErectileFunction. Urology , 1999; 54: 346–351
Consortium for Spinal Cord Medicine. Sexuality and Reproductive Health in Adults with Spinal
Mitko D. Mitkov, Ivanka Y. Aleksandrova and Maria M. Orbetzova
1. NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence. JAMA 1993;270(1):83-90.
2. Hatzimouratidis K, Hatzichristou D. Testosterone and erectilefunction: an unresolved enigma. Eur Urol 2007;52(1):54-70.
3. Feldman HA, Longcope C, Derby CA, Johannes CB, Araujo AB, Coviello AD, et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts Male Aging Study. J Clin Endocrinol Metab 2002
Norbert A. Szekeres, Zsuzsánna Jeremiás, Árpád Olivér Vida, Orsolya Mártha and Daniel Porav-Hodade
of the longitudinal Massachussetts male aging study. Soc Sci Med . 2000;51(5):771-778.
27. Meller SM, Stilp E, Walker CN, Mena-Hurtado C. The link between vasculogenic erectile dysfunction, coronary artery disease, and peripheral artery disease: role of metabolic factors and endovascular therapy. J Invasive Cardiol . 2013;25(6):313-319.
28. Greenstein A, Chen J, Miller H, Matzkin H, Villa Y, Braf Z. Does severity of ischemiccoronary disease correlate with erectilefunction? Int J Impot Res . 1997;9(3):123-126.
29. Gupta BP, Clifton MM, Prokop L
evaluation of erectile dysfunction? Int J Impot Res 2001; 13 : 200-4.
Allen RP, Smolev JK, Engel RM, Brendler CB. Comparison of Rigiscan and formal nocturnal penile tumescence testing in the evaluation of erectile rigidity. J Urol 1993; 149 : 1265-8.
Rosselló Barbará M. Digital inflection rigidometry in the study of erectile dysfunction. A new technique. Arch Esp Urol 1996; 49 : 221-7.
El-Sakka AI. Association between International Index of ErectileFunction and axial penile rigidity in
We aimed to compare results between patients with early- stage prostate cancer who underwent robot-assisted and open radical prostatectomy. We examined preoperative and postoperative data, early and late complications, and analysed oncological and functional outcomes (continence and erectile function) during follow-up.
We studied the data of 123 patients with localized prostate cancer, operated with nerve-sparing retropubic radical prostatectomy, divided into two groups. Group 1 included 70 patients who underwent robot-assisted radical prostatectomy (RARP). Group 2 included 53 patients, on whom open retropubic radical prostatectomy (RRP) was performed. We compared preoperative data, complications rate, oncological, and functional outcome (continence and erectile function) during the follow-up period.
Operative time was significantly lower in the RRP group. Blood loss and earlier removal of the urinary catheter were significantly lower in the RARP group. The percentage of significant postoperative complications (Clavien-Dindo III-IV) was 0% in the first group and 3% in the second group. During follow-up, the improvement in the functional outcome - continence and erectile function was significantly better in the robot-assisted surgery patients.
There were statistically significant better functional outcomes in patients operated on using the robot-assisted technique. The operating time was shorter in the classic radical prostatectomy. The application of robot-assisted radical prostatectomy may help achieve earlier recovery, as compared to open radical prostatectomy.
Nikolay H. Kolev, Jitian A. Atanasov, Vladislav R. Dunev, Boyan A. Stoykov, Rumen P. Kotsev, Alexander Vanov, Fahd Al-Shargabi, Pencho T. Tonchev, Sergey D. Iliev and Toni I. Stoyanov
Prostate cancer (PC) is the most common type of cancer in men inanumber of countries. The choice of surgical technique for radical prostatectomy (RP) concerns both patients and urologists. The choice is not easy to make, since data is still limited due to the lack of large multicentric randomized research trials. For three years (2011-2014), 244 patients with limited prostate cancer were operated in the Urology Clinic of the University Hospital in Pleven. Robot-assisted radical prostatectomy (RARP) was performed on 35 patients (14%), open retropubic radical prostatectomy (ORP) - on 199 patients (81%), and laparoscopic RP - on 12 patients (5%). The preoperative and post-op results from the first two groups were compared. For the follow-up period of 12 months, functional results in 82 patients of the ORPgroup were compared to the results in the 35 patients of the RARPgroup. The operative time was significantly longer in the RARPgroup, and blood loss was lower. The catheter stay was shorter in patients with RARP. The percentage of significant postoperative complications was 0%in the patients with RARPand 3%in the patients with an ORP. RARPpatients demonstrated better continence: 91%vs. 87%and erectile function46%vs.40%at 12 months.